About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

FDA Offers Full Approval for Amgen’s Blood Cancer Drug ‘Krypolis’

by Reshma Anand on January 23, 2016 at 2:34 PM
Font : A-A+

FDA Offers Full Approval for Amgen’s Blood Cancer Drug ‘Krypolis’

The US food and Drug Administration has announced that it has approved Amgen's supplemental new drug application for Kyprolis in combination with dexamethasone and Revlimid (lenalidomide) for the treatment of refractory multiple myeloma.

Krypolis can now be used for treating patients with relapse or refractory multiple myeloma who have received one to three treatment before.

Advertisement


The drug was approved as a single agent by the FDA in 2012 and now it has expanded it into full approval.

Amgen said, "The agency approved Kyprolis in combination with dexamethasone or with the drug lenalidomide plus dexamethasone for relapsed or refractory patients. It approved the drug as a single agent for patients with relapsed or refractory disease who have received one or more treatments."

Source: Medindia
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Diet and Oral Health: The Sugary Connection May Become Sour
World AIDS Day 2022 - Equalize!
Test Your Knowledge on Sugar Intake and Oral Health
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Thalassemia Cancer and Homeopathy Signature Drug Toxicity Cancer Facts Cancer Tattoos A Body Art Hairy Cell Leukemia Blood in Stools - Symptom Evaluation Bombay Blood Group 

Most Popular on Medindia

Find a Doctor Hearing Loss Calculator Blood - Sugar Chart Selfie Addiction Calculator A-Z Drug Brands in India Accident and Trauma Care Loram (2 mg) (Lorazepam) Blood Pressure Calculator Pregnancy Confirmation Calculator Drug - Food Interactions
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

FDA Offers Full Approval for Amgen’s Blood Cancer Drug ‘Krypolis’ Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests